Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Carbohydr Polym ; 267: 118161, 2021 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-34119135

RESUMO

In this study we described the synthesis of a hybrid polysaccharide harboring moieties of ulvan and kappa-carrabiose. Alkylamines (1,3-diaminopropane and 1,6-diaminohexane) were selectively inserted into ß-D-GlcAp and α-L-IdoAp units in the ulvan structure via an amide bond formation producing ulvan-amide derivatives F-DAP (N% = 1.77; Mw = 208 kg mol-1) and F-DAH (N% = 1.77; Mw = 202 kg mol-1), which were reacted with kappa-carrabiose via reductive amination to produce hybrid ulvan-kappa-carrabiose polysaccharides F-DAP-Kb (N% = 1.56; Mw = 206 kg mol-1) and F-DAH-Kb (N% = 1.16; Mw = 200 kg mol-1). All the ulvan derivatives were characterized by 1H and 13C NMR spectroscopy and did not show cytotoxicity against human dermal fibroblasts (HDFa) at the concentrations of 25, 100, and 500 µg mL-1, neither anticoagulant properties at the range of 10-150 µg mL-1. Therefore, the ulvan-amide derivatives and the hybrid ulvan-kappa-carrabiose polysaccharides showed good biocompatibility in vitro, presenting as worthy candidates for tailoring scaffolds for biomedical applications.


Assuntos
Anticoagulantes/farmacologia , Carragenina/farmacologia , Polissacarídeos/farmacologia , Anticoagulantes/síntese química , Anticoagulantes/toxicidade , Carragenina/síntese química , Carragenina/toxicidade , Fibroblastos/efeitos dos fármacos , Humanos , Tempo de Tromboplastina Parcial , Polissacarídeos/síntese química , Polissacarídeos/toxicidade
2.
Carbohydr Polym ; 197: 631-640, 2018 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-30007656

RESUMO

Native (F2) and carboxyl-reduced (R) ulvans from Ulva fasciata were sequentially oxidized with periodate-chlorite affording the polycarboxyl ulvans C1, C2 and C3 (1.20, 1.41 and 1.81 mmol g-1 of COOH, respectively; 19.7, 21.3 and 21.0% of NaSO3, respectively) and R-C3 (1.86 mmol g-1 of COOH; NaSO3 = 22.7%), respectively. APTT assay (polysaccharide fractions at 150 µg mL-1) showed clotting time of 45.6 s for F2 fraction. For polycarboxyl ulvans C1, C2, C3 and R-C3 the clotting times were 101.0, 122.2, 222.0 and 227.0 s, respectively. Comparison of the APTT assay results using ulvans chemically modified by carboxyl-reduction, desulfation, periodate oxidation and/or chlorite oxidation showed the anticoagulant activity of polycarboxyl ulvans is dependent of the sulfate groups present in the native polymer. In addition, the increase of the anticoagulant activity was accompanied by the increasing of the carboxyl groups and the content of this acidic substituent seems to be more important than its positioning.


Assuntos
Anticoagulantes/farmacologia , Fatores de Coagulação Sanguínea/antagonistas & inibidores , Cloretos/farmacologia , Ácido Periódico/farmacologia , Polissacarídeos/farmacologia , Anticoagulantes/química , Cloretos/química , Relação Dose-Resposta a Droga , Conformação Molecular , Oxirredução , Ácido Periódico/química , Polissacarídeos/química
3.
Carbohydr Polym ; 101: 313-23, 2014 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-24299779

RESUMO

The anti-HMPV (human metapneumovirus) activity was determined for sulfated dl-hybrid galactans obtained from the red seaweed Cryptonemia seminervis and their depolymerized products obtained by reductive partial hydrolysis. Structural studies carried out in three homogeneous depolymerized fractions DS-1, DS-2e and DS-3 (Mw of 51.6-63.8 kDa) showed that these galactans present different chemical characteristics, as monosaccharide composition, content of sulfate groups (14.1-29.9%) and agaran:carrageenan molar ratio diads, 2.7:1 for DS-1 and DS-2e and 1:1 for DS-3. The sulfate groups are located principally on C-2 of ß-d-galactopyranose and 4,6-O-(1'-carboxyethylidene)-ß-d-galactopyranose residues and on C-6 of α-galactose residues. Sulfated dl-galactans and their depolymerized products exhibited antiviral activity at a very early stage of the viral infection cycle. All fractions, except DS-2e inhibited HMPV replication by binding to the viral particle. Besides depolymerized galactans DS-2e and DS-3 inhibited the recognition of cell receptor by HMPV and penetration to the host cell, respectively.


Assuntos
Antivirais/química , Antivirais/farmacologia , Galactanos/química , Galactanos/farmacologia , Metapneumovirus/efeitos dos fármacos , Rodófitas/química , Sulfatos/química , Animais , Antivirais/toxicidade , Linhagem Celular , Galactanos/toxicidade , Humanos , Polimerização
4.
Carbohydr Res ; 344(17): 2364-74, 2009 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-19800614

RESUMO

Cryptonemia seminervis biosynthesizes a family of D,L-hybrid galactans based on the classical 3-linked beta-D-galactopyranosyl-->4-linked alpha-D- and alpha-L-galactopyranosyl alternating sequence (A-units-->B-units) with major amounts of alpha-D- and alpha-L-galactose and 3,6-anhydro-D- and L-galactose and lesser percentages of 3,6-anhydro-2-O-methyl-L-galactose, 2-O-methyl-, 4-O-methyl- and 6-O-methylgalactoses. The dispersion of structures in this family is based on five structural factors, namely: (a) the amount and position of substituent groups as sulfate (major), pyruvic acid ketals, methoxyl and glycosyl side-chain (4-O-methyl galactopyranosyl and/or xylosyl); (b) the ratio galactose/3,6-anhydrogalactose in the B-units; (c) the ratio D,L-galactoses and D,L-3,6-anhydrogalactoses also in the B-units, (d) the formation of diads and (e) the sequence of the diads in the linear backbone. Considering these variables it is not unexpected to find in the fractions studied at least 18 structural units producing highly complex structures. Structural studies carried out in two major fractions (S2S-3 and S2S-4) showed that these galactans were formed mainly by beta-D-galactopyranosyl 2-sulfate (20 and 11.9 mol%), beta-d-galactopyranosyl 2-sulfate 4,6-O-(1'-carboxyethylidene) (8.9 and 6.0 mol%) and beta-D-galactopyranosyl 2,6-sulfate (5.4 and 18.6 mol%), together with 3,6-anhydro-alpha-l-galactopyranosyl (11.4 and 7.3 mol%) and 3,6-anhydro-alpha-L-galactopyranosyl 2-sulfate (4.9 and 15.4 mol%) and minor quantities of 12-15 other structural units. Preparative alkaline treatment carried out on fraction (S2S-3) produced a quantitative formation of 3,6-anhydro alpha-L-galactopyranosyl units from precursor units (alpha-L-galactose 6-sulfate and alpha-L-galactose 2,6-sulfate). Kinetic studies on this 3,6-anhydro cyclization show a rate constant of 5.2 x 10(4)s(-1) indicating diads of the type G-->L6S/2,6S. Data from chemical, spectroscopic and kinetic studies suggest that, in S2S-3, the agaran block in the D,L-hybrid galactan is composed of the following diads: G(6R)-->L6S/2,6S and G2S(P)(2,6S)-->LA(2S)(2R)(2M) and the carrageenan block of G2S(P)-->D(2S)(2,3S)(3S)(3,6S) in a molar ratio of agaran to carrageenan structures of approximately 2:1.


Assuntos
Galactanos/química , Rodófitas/química , Ressonância Magnética Nuclear Biomolecular , Espectroscopia de Infravermelho com Transformada de Fourier
5.
Rev. bras. farmacogn ; 21(2): 296-304, mar.-abr. 2011. ilus, graf, tab
Artigo em Inglês | LILACS | ID: lil-590197

RESUMO

Agaro- and carra-oligosaccharides were produced by partial acid hydrolysis of commercial agarose and kappa-carrageenan. Di- and tetrasaccharides were purified by gel filtration chromatography and characterized by NMR (1D and 2D) spectroscopy and ESIMS. The following oligosaccharides were obtained: agarobiose, agarotetraose, kappa-carrabiose and kappa-carratetraose. Agarobiose and agarotetraose were used as standards to develop a high performance size exclusion chromatography (HPSEC) method which was utilized to study the hydrolysis rate of agarose and oligosaccharide production. Six hours of hydrolysis (0.1 M TFA, 65 ºC) produced mainly di- and tetrasaccharides. The methodology for oligosaccharide production and evaluation developed in the present work shows good potential for the production of bioactive oligosaccharides.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA